The relation between CD40 ligand and coronary artery disease

Cardiology (Switzerland)

Volumn 131, Issue 2, 2015, Pages 107-108

  Balta, Sevket ^a   Ozturk, Cengiz ^b  

^a Eskisehir Military Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ADIPOCYTE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CORONARY ARTERY DISEASE; EDITORIAL; FOAM CELL; HUMAN; LIPID STORAGE; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THROMBOSIS; METABOLISM;

ATHEROSCLEROSIS; CD40 LIGAND; FOAM CELLS; HUMANS; LIPOPROTEINS, LDL;

EID: 84928102461     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000381180     Document Type: Editorial

References (8)

1. Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G: Atherosclerosis as an inflammatory disease. Curr Pharm Des 2012; 18: 4266-4288.
2. Pamukcu B, Lip GYH, Snezhitskiy V, Shantsila E: The CD40-CD40L system in cardiovascular disease. Ann Med 2011; 43: 331-340.
3. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998; 394: 200-203.
4. Mach F, Schönbeck U, Libby P: CD40 signaling in vascular cells: a key role in atherosclerosis Atherosclerosis 1998; 137(suppl):S89-S95.
5. Häkkinen T, Karkola K, Ylä-Herttuala S: Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc). Virchows Arch 2000; 437: 396-405.
6. Yuan M, Fu H, Ren L, Wang H, Guo W: Soluble CD40 ligand promotes macrophage foam cell formation in the etiology of atherosclerosis. Cardiology 2015;131:1-12.
7. Zhang B, Wu T, Chen M, Zhou Y, Yi D, Guo R: The CD40/CD40L system: a new therapeutic target for disease. Immunol Lett 2013; 153: 58-61.
8. Rizvi M, Pathak D, Freedman JE, Chakra barti S: CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med 2008; 14: 530-538.